Subtype
Liver Carcinoma
CI-CAN-00001073Explore in graph →
783 active trials14 approved drugs17 evidence items
- NCIt
- C7927
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001073Explore in graph →
Clinical trials
3,370 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (387)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02115373 | c-Met Second-Line Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 66 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Aug 24, 2022 | clinicaltrials |
| NCT03232593 | A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) | completed | — | 1,758 | Hoffmann-La RocheINDUSTRY | 1 | Aug 24, 2022 | clinicaltrials |
| NCT02141906 |
| A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin |
| completed |
| Phase 2 |
| 20 |
| University of Texas Southwestern Medical CenterOTHER |
| 1 |
| Aug 18, 2022 |
| clinicaltrials |
| NCT05502458 | Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor | completed | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT05489692 | HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma | completed | — | 43 | Sun Yat-sen UniversityOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT03163992 | Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib | completed | Phase 2 | 60 | Samsung Medical CenterOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT05464706 | Study on the Quality of Life (QoL) After Liver Surgery | completed | N/A | 60 | Humanitas Clinical and Research CenterOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT01896778 | Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | completed | N/A | 9 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT02072486 | Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | completed | N/A | 30 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT02412579 | Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation | completed | — | 40 | Baylor Research InstituteOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT03982407 | 68 Ga PSMA PET/MRI for Hepatocellular Carcinoma | completed | Early Phase 1 | 5 | Ajit H. Goenka, MDOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT02095678 | Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions | completed | N/A | 52 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT02686372 | A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation | completed | Phase 1 | 13 | Lion TCR Pte. Ltd.INDUSTRY | 1 | Jun 30, 2022 | clinicaltrials |
| NCT02929082 | Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer(FORCE) | completed | N/A | 97 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 24, 2022 | clinicaltrials |
| NCT00247728 | PI-88 in Hepatocellular Carcinoma After Hepatectomy | completed | Phase 2 | 172 | Cellxpert Biotechnology Corp.INDUSTRY | 1 | Jun 23, 2022 | clinicaltrials |
| NCT05406089 | Effects of Antiviral Therapy on Patients With HBV-related HCC | completed | — | 494 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Jun 21, 2022 | clinicaltrials |
| NCT02243384 | Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma | completed | N/A | 150 | ChenJianOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT03156582 | Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)(Impact AFP) | completed | — | 562 | University Hospital, GrenobleOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT00790218 | A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 19 | Can-Fite BioPharmaINDUSTRY | 1 | May 17, 2022 | clinicaltrials |
| NCT04303286 | The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma | completed | — | 200 | Tongji HospitalOTHER | 1 | May 12, 2022 | clinicaltrials |
| NCT04027556 | Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction | completed | N/A | 90 | Seoul National University HospitalOTHER | 1 | May 4, 2022 | clinicaltrials |
| NCT05355662 | Prognosis Analysis of Elderly Donor Liver in Liver Transplantation | completed | — | 11,569 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | May 2, 2022 | clinicaltrials |
| NCT01929902 | Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery | completed | — | 20 | Wake Forest University Health SciencesOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT00605150 | HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC | completed | — | 11 | Wake Forest University Health SciencesOTHER | 0 | Apr 22, 2022 | clinicaltrials |
| NCT01666145 | Advanced Image Guidance Utilized in Liver Surgery | completed | N/A | 14 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT05068193 | A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers | completed | Phase 1 | 57 | Boryung Pharmaceutical Co., LtdINDUSTRY | 1 | Apr 20, 2022 | clinicaltrials |
| NCT02354898 | A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 1 | 60 | Sumitomo Pharma Co., Ltd.INDUSTRY | 1 | Apr 12, 2022 | clinicaltrials |
| NCT02358395 | A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 12 | Sumitomo Pharma Co., Ltd.INDUSTRY | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04767750 | Role of LncRNA H19 in The Regulation of IGF-1R Expression | completed | — | 101 | Mansoura UniversityOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT04659005 | Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening | completed | N/A | 178 | Chinese University of Hong KongOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04903340 | Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy(PYR) | completed | — | 30 | University Hospital, BordeauxOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02906397 | Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 15 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT01340105 | Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation | completed | N/A | 93 | Chinese University of Hong KongOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT03259581 | Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin | completed | Phase 1 | 5 | University of MinnesotaOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT01512407 | RCT on Adjuvant TACE After Hepatectomy for HCC(A-TECH) | completed | N/A | 58 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT01759901 | Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma | completed | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT02785835 | Hepatocellular Carcinoma in HIV-infected Patients(GEHEP-002) | completed | — | 477 | Hospital Universitario de ValmeOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT05281783 | RFA for Treatment of Intermediate Stage HCC | completed | N/A | 120 | Benha UniversityOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT04008082 | A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma | completed | — | 412 | Eisai Co., Ltd.INDUSTRY | 1 | Mar 8, 2022 | clinicaltrials |
| NCT04212286 | Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC | completed | N/A | 115 | Tianjin Third Central HospitalOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT02178358 | A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 132 | Eli Lilly and CompanyINDUSTRY | 5 | Feb 25, 2022 | clinicaltrials |
| NCT03884751 | Chimeric Antigen Receptor T Cells Targeting Glypican-3 | completed | Phase 1 | 9 | CARsgen Therapeutics Co., Ltd.INDUSTRY | 1 | Feb 24, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 | clinicaltrials |
| NCT04722120 | Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC | completed | N/A | 68 | Seoul National University HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT02392637 | Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers | completed | Phase 2 | 62 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT04811898 | A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment(LNA-i-miR221) | completed | Phase 1 | 17 | Azienda Ospedaliera Universitaria Mater Domini, CatanzaroOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT02947165 | Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. | completed | Phase 1 | 120 | Novartis PharmaceuticalsINDUSTRY | 9 | Jan 31, 2022 | clinicaltrials |
| NCT02837029 | Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer | completed | Phase 1 | 27 | Northwestern UniversityOTHER | 1 | Jan 25, 2022 | clinicaltrials |
| NCT05193253 | Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less | completed | — | 119 | University Health Network, TorontoOTHER | 0 | Jan 18, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Aug 24, 2022source: clinicaltrials